Antiglioma effects of cytarabine on leptomeningeal metastasis of high-grade glioma by targeting the PI3K/Akt/mTOR pathway
Kai-Hong Zhao,1 Can Zhang,2 Yue Bai,1 Yan Li,1 Xun Kang,1 Jian-Xin Chen,1 Kun Yao,3 Tao Jiang,4 Xiao-Song Zhong,2 Wen-Bin Li1 1Department of Glioma, 2Clinical Center of Gene And Cell Engineering, Beijing Shijitan Hospital, 3Department of Neurosurgery, Beijing Tiantan Hospital, 4Department of Pathol...
| Main Authors: | , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Dove Medical Press
2017-06-01
|
| Series: | Drug Design, Development and Therapy |
| Subjects: | |
| Online Access: | https://www.dovepress.com/antiglioma-effects-of-cytarabine-on-leptomeningeal-metastasis-of-high--peer-reviewed-article-DDDT |
| _version_ | 1818343985019617280 |
|---|---|
| author | Zhao KH Zhang C Bai Y Li Y Kang X Chen JX Yao K Jiang T Zhong XS Li WB |
| author_facet | Zhao KH Zhang C Bai Y Li Y Kang X Chen JX Yao K Jiang T Zhong XS Li WB |
| author_sort | Zhao KH |
| collection | DOAJ |
| description | Kai-Hong Zhao,1 Can Zhang,2 Yue Bai,1 Yan Li,1 Xun Kang,1 Jian-Xin Chen,1 Kun Yao,3 Tao Jiang,4 Xiao-Song Zhong,2 Wen-Bin Li1 1Department of Glioma, 2Clinical Center of Gene And Cell Engineering, Beijing Shijitan Hospital, 3Department of Neurosurgery, Beijing Tiantan Hospital, 4Department of Pathology, Sanbo Brain Hospital, Capital Medical University, Beijing, People’s Republic of China Abstract: Leptomeningeal metastasis (LM) of high-grade glioma is a highly lethal disease requiring new effective therapeutic measures. For both de novo or relapsed glioma with LM, intrathecal cytarabine chemotherapy is not frequently used for first-line and relapse protocols. We encountered a clinical case demonstrating effective application of cytarabine in high-grade glioma with LM, prompting us to explore the effects of cytarabine on malignant glioma and molecular mechanisms of such effects through in vivo and in vitro experiments. The U87 cell line was selected to represent human glioma for studies. Cell viability was measured by MTT assay, plate colony formation assay, and trypan-blue dye exclusion test. Apoptosis was assessed by flow cytometry. Protein expression levels were detected by Western blot assay and immunohistochemistry. mRNA expression was examined by quantitative real-time reverse transcription polymerase chain reaction. Cytarabine inhibited tumor growth during the in vivo experiment. The present study confirmed that cytarabine inhibits proliferation and promotes apoptosis of U87 cells, and molecular analysis of this effect showed that cytarabine significantly reduces expression of phosphatidylinositol 3-kinase/serine/threonine kinase also known as the protein kinase B/mechanistic target of rapamycin (PI3K/Akt/mTOR) pathway, Ki-67, BCL2, and 4-1BB, and upregulates Bax and cleaved caspase-3. Our findings indicated that intrathecal administration of cytarabine manifests potential in prophylaxis and treatment of malignant glioma with LM. Effective medications for high-grade glioma with LM should contain cytarabine. Keywords: leptomeningeal metastases, malignant glioma, cytarabine, PI3K/Akt/mTOR |
| first_indexed | 2024-12-13T16:39:16Z |
| format | Article |
| id | doaj.art-4a9b7625924e403c9c73b323c6c8016b |
| institution | Directory Open Access Journal |
| issn | 1177-8881 |
| language | English |
| last_indexed | 2024-12-13T16:39:16Z |
| publishDate | 2017-06-01 |
| publisher | Dove Medical Press |
| record_format | Article |
| series | Drug Design, Development and Therapy |
| spelling | doaj.art-4a9b7625924e403c9c73b323c6c8016b2022-12-21T23:38:19ZengDove Medical PressDrug Design, Development and Therapy1177-88812017-06-01Volume 111905191533448Antiglioma effects of cytarabine on leptomeningeal metastasis of high-grade glioma by targeting the PI3K/Akt/mTOR pathwayZhao KHZhang CBai YLi YKang XChen JXYao KJiang TZhong XSLi WBKai-Hong Zhao,1 Can Zhang,2 Yue Bai,1 Yan Li,1 Xun Kang,1 Jian-Xin Chen,1 Kun Yao,3 Tao Jiang,4 Xiao-Song Zhong,2 Wen-Bin Li1 1Department of Glioma, 2Clinical Center of Gene And Cell Engineering, Beijing Shijitan Hospital, 3Department of Neurosurgery, Beijing Tiantan Hospital, 4Department of Pathology, Sanbo Brain Hospital, Capital Medical University, Beijing, People’s Republic of China Abstract: Leptomeningeal metastasis (LM) of high-grade glioma is a highly lethal disease requiring new effective therapeutic measures. For both de novo or relapsed glioma with LM, intrathecal cytarabine chemotherapy is not frequently used for first-line and relapse protocols. We encountered a clinical case demonstrating effective application of cytarabine in high-grade glioma with LM, prompting us to explore the effects of cytarabine on malignant glioma and molecular mechanisms of such effects through in vivo and in vitro experiments. The U87 cell line was selected to represent human glioma for studies. Cell viability was measured by MTT assay, plate colony formation assay, and trypan-blue dye exclusion test. Apoptosis was assessed by flow cytometry. Protein expression levels were detected by Western blot assay and immunohistochemistry. mRNA expression was examined by quantitative real-time reverse transcription polymerase chain reaction. Cytarabine inhibited tumor growth during the in vivo experiment. The present study confirmed that cytarabine inhibits proliferation and promotes apoptosis of U87 cells, and molecular analysis of this effect showed that cytarabine significantly reduces expression of phosphatidylinositol 3-kinase/serine/threonine kinase also known as the protein kinase B/mechanistic target of rapamycin (PI3K/Akt/mTOR) pathway, Ki-67, BCL2, and 4-1BB, and upregulates Bax and cleaved caspase-3. Our findings indicated that intrathecal administration of cytarabine manifests potential in prophylaxis and treatment of malignant glioma with LM. Effective medications for high-grade glioma with LM should contain cytarabine. Keywords: leptomeningeal metastases, malignant glioma, cytarabine, PI3K/Akt/mTORhttps://www.dovepress.com/antiglioma-effects-of-cytarabine-on-leptomeningeal-metastasis-of-high--peer-reviewed-article-DDDTleptomeningeal metastasesmalignant gliomacytarabinePI3K/Akt/m-TOR |
| spellingShingle | Zhao KH Zhang C Bai Y Li Y Kang X Chen JX Yao K Jiang T Zhong XS Li WB Antiglioma effects of cytarabine on leptomeningeal metastasis of high-grade glioma by targeting the PI3K/Akt/mTOR pathway Drug Design, Development and Therapy leptomeningeal metastases malignant glioma cytarabine PI3K/Akt/m-TOR |
| title | Antiglioma effects of cytarabine on leptomeningeal metastasis of high-grade glioma by targeting the PI3K/Akt/mTOR pathway |
| title_full | Antiglioma effects of cytarabine on leptomeningeal metastasis of high-grade glioma by targeting the PI3K/Akt/mTOR pathway |
| title_fullStr | Antiglioma effects of cytarabine on leptomeningeal metastasis of high-grade glioma by targeting the PI3K/Akt/mTOR pathway |
| title_full_unstemmed | Antiglioma effects of cytarabine on leptomeningeal metastasis of high-grade glioma by targeting the PI3K/Akt/mTOR pathway |
| title_short | Antiglioma effects of cytarabine on leptomeningeal metastasis of high-grade glioma by targeting the PI3K/Akt/mTOR pathway |
| title_sort | antiglioma effects of cytarabine on leptomeningeal metastasis of high grade glioma by targeting the pi3k akt mtor pathway |
| topic | leptomeningeal metastases malignant glioma cytarabine PI3K/Akt/m-TOR |
| url | https://www.dovepress.com/antiglioma-effects-of-cytarabine-on-leptomeningeal-metastasis-of-high--peer-reviewed-article-DDDT |
| work_keys_str_mv | AT zhaokh antigliomaeffectsofcytarabineonleptomeningealmetastasisofhighgradegliomabytargetingthepi3kaktmtorpathway AT zhangc antigliomaeffectsofcytarabineonleptomeningealmetastasisofhighgradegliomabytargetingthepi3kaktmtorpathway AT baiy antigliomaeffectsofcytarabineonleptomeningealmetastasisofhighgradegliomabytargetingthepi3kaktmtorpathway AT liy antigliomaeffectsofcytarabineonleptomeningealmetastasisofhighgradegliomabytargetingthepi3kaktmtorpathway AT kangx antigliomaeffectsofcytarabineonleptomeningealmetastasisofhighgradegliomabytargetingthepi3kaktmtorpathway AT chenjx antigliomaeffectsofcytarabineonleptomeningealmetastasisofhighgradegliomabytargetingthepi3kaktmtorpathway AT yaok antigliomaeffectsofcytarabineonleptomeningealmetastasisofhighgradegliomabytargetingthepi3kaktmtorpathway AT jiangt antigliomaeffectsofcytarabineonleptomeningealmetastasisofhighgradegliomabytargetingthepi3kaktmtorpathway AT zhongxs antigliomaeffectsofcytarabineonleptomeningealmetastasisofhighgradegliomabytargetingthepi3kaktmtorpathway AT liwb antigliomaeffectsofcytarabineonleptomeningealmetastasisofhighgradegliomabytargetingthepi3kaktmtorpathway |